Cargando...
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT
Human herpesvirus 6B (HHV-6B) frequently reactivates after allogeneic hematopoietic cell transplantation (HCT). There are no randomized studies of antiviral treatments to prevent HHV-6B reactivation. Brincidofovir has high in vitro activity against HHV-6B and other DNA viruses, but its in vivo activ...
Gardado en:
| Publicado en: | Blood |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7180083/ https://ncbi.nlm.nih.gov/pubmed/32076716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004315 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|